Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 20/20 | 0.70 |
| ▸ | LIFR | P42702 | 3/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | FABP1 | P07148 | 1/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | HSD17B13 | Q7Z5P4 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4421558 | 0.94 | NR1H4 (0.72) | NR1H4LIFRMEN1FABP1THRB | |
| SCHEMBL4429498 | 0.90 | NR1H4 (0.75) | NR1H4LIFRMEN1FABP1THRB | |
| SCHEMBL4424716 | 0.86 | NR1H4 (0.72) | NR1H4LIFRMEN1FABP1THRB | |
| SCHEMBL4421519 | 0.85 | NR1H4 (0.75) | NR1H4LIFRMEN1FABP1THRB | |
| SCHEMBL4433150 | 0.85 | NR1H4 (0.66) | NR1H4LIFRMEN1FABP1THRB | |
| SCHEMBL4427382 | 0.84 | NR1H4 (0.69) | NR1H4LIFRMEN1FABP1THRB | |
| SCHEMBL4426866 | 0.83 | NR1H4 (0.86) | NR1H4LIFRMEN1FABP1THRB | |
| SCHEMBL30080777 | 0.83 | NR1H4 (1.00) | NR1H4LIFRMEN1FABP1THRB | |
| SCHEMBL28535262 | 0.83 | NR1H4 (1.00) | NR1H4LIFRMEN1FABP1THRB | |
| SCHEMBL4840153 | 0.83 | NR1H4 (0.66) | NR1H4LIFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7319109-B2 | Farnesoid X receptor agonists | SMITH KLINE BEECHAM CORPORATION (US) | 2008-01-15 | — | — | US | disclosed |